Finally, the gene (FOS) from the breast cancer stage II pattern, physically interacts with JUN, a target gene of Vinblastine Breast cancer drug and with NR3C1, a target gene of Megestrol Breast cancer drug (Fig. 11). The gene discussed is FOS; the disease is breast carcinoma.